Stocks
Pacira BioSciences, Inc.PCRX
NASDAQHealthcareBiotechnology$23.26-1.15%
A pharmaceutical company focused on non‑opioid pain management therapies used primarily in surgical and musculoskeletal settings. Its flagship product, Exparel, is a long‑acting local anesthetic widely used for postsurgical pain control, with additional products and pipeline candidates targeting ort...
Market Cap: $1.0B52W Range: $18.80 – $27.64
Congressional Interest in Pacira BioSciences, Inc. (PCRX)
4 members of Congress have disclosed 19 trades in Pacira BioSciences, Inc. (PCRX), a Healthcare company. The buy/sell breakdown shows 17 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
19
Unique Politicians
4
Buys
17
Sells
2
Who in Congress Is Trading PCRX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-01-31 | Bradley S. Schneider | buy | $1K – $15K |
| 2021-05-06 | Tom Malinowski | buy | $1K – $15K |